Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Microvascular autophagy and caspase-3 activation are central regulators of renal fibrosis after ischemia-reperfusion
Hyunyun Kim, Francis Migneault, Shanshan Lan, Imane Kaci, Julie Turgeon, Annie Karakeussian Rimbaud, Martin Dupont, Shijie Qi, Mélanie Dieudé, Marie-Josée Hébert
Hyunyun Kim, Francis Migneault, Shanshan Lan, Imane Kaci, Julie Turgeon, Annie Karakeussian Rimbaud, Martin Dupont, Shijie Qi, Mélanie Dieudé, Marie-Josée Hébert
View: Text | PDF
Research Article Nephrology Vascular biology

Microvascular autophagy and caspase-3 activation are central regulators of renal fibrosis after ischemia-reperfusion

  • Text
  • PDF
Abstract

Ischemia-reperfusion injury (IRI) is a common cause of acute kidney injury (AKI) leading to renal fibrosis. Here, we investigate the kinetics of autophagy, apoptosis, and necroptosis activation in tubular epithelial cells (TECs) and peritubular capillaries (PTCs) after renal IRI, and their relative contributions to renal fibrogenesis. IRI with renal artery clamping in GFP-LC3 transgenic mice induced a predominant and sustained necroptotic response in TECs, while apoptosis and autophagy played minor roles. PTCs showed early and persistent activation of apoptosis, brief necroptosis induction, and increased autophagy at a distance from IRI. Disruption of the autophagic process with chloroquine (CHQ) injections in association with renal IRI did not modulate tubular death but enhanced PTC apoptosis and increased microvascular rarefaction and fibrosis. Apoptosis-deficient GFP-LC3/Caspase-3–/– mice exposed to renal IRI showed enhanced PTC autophagy, reduced PTC rarefaction, and inhibition of renal fibrosis, in spite of increased necroptosis in TECs. Inhibition of both autophagy with CHQ and apoptosis in GFP-LC3/Caspase-3–/– mice led to a marked switch toward necroptosis in PTCs. This was associated with aggravated microvascular rarefaction, increased leukocyte infiltration, and enhanced renal fibrosis. These findings establish a predominant role for PTC autophagy and caspase-3–dependent apoptosis in the development of renal fibrosis after IRI.

Authors

Hyunyun Kim, Francis Migneault, Shanshan Lan, Imane Kaci, Julie Turgeon, Annie Karakeussian Rimbaud, Martin Dupont, Shijie Qi, Mélanie Dieudé, Marie-Josée Hébert

×

Figure 10

Autophagy disruption and caspase-3 deficiency worsen microvascular rarefaction, fibrosis, and leukocyte infiltration following renal IRI.

Options: View larger image (or click on image) Download as PowerPoint
Autophagy disruption and caspase-3 deficiency worsen microvascular raref...
(A–E) Quantification of the relative change in specific markers within peritubular capillaries (PTCs) of GFP-LC3/Caspase-3+/+ and GFP-LC3/Caspase-3–/– mice injected with chloroquine (CHQ) compared to those injected with PBS (n = 5–7 per group). (A) Relative change in GFP-LC3+ puncta. Representative images show autophagic puncta (white arrows) in renal PTCs using immunofluorescence (IF) staining for GFP-LC3 (green), PLVAP (magenta), and DAPI (blue). IR30m, 30-minute ischemia/reperfusion. (B) Relative change in SQSTM1/p62+ PTCs. Representative images show SQSTM1/p62 immunohistochemistry (IHC) in PTCs, with white arrows indicating SQSTM1/p62+ cells. (C) Relative change in p-RIPK3 IHC in PTCs. Representative images show p-RIPK3 IHC in PTCs, with white arrows indicating p-RIPK3+ PTCs. (D) Relative change in microvascular density. Representative images show PLVAP IHC in kidney tissue. (E) Relative change in α-smooth muscle actin+ (ACTA2+) PTCs. Representative images show ACTA2 IHC in PTCs, with white arrows indicating ACTA2+ cells. (F) Quantification of the ratio of CD45+ area to total tissue area (n = 5–7). Representative images of the CD45+ area. For each kidney, 10 randomly selected high-power fields (original magnification, ×200) were evaluated, consisting of 5 fields from the cortex and 5 from the corticomedullary junction. Scale bars: 50 μm (IHC) and 5 μm (IF). Values are mean ± SEM. P values obtained by 1-way ANOVA with Bonferroni’s post hoc test. #P < 0.05, ##P < 0.01, ####P < 0.0001 compared with the respective PBS-treated group; *P < 0.05, **P < 0.01 compared with the CHQ-injected group.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts